NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 159 filers reported holding NOVAVAX INC in Q2 2015. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,276,000 | -39.5% | 1,013,039 | -0.1% | 0.00% | -66.7% |
| Q3 2016 | $2,110,000 | -71.1% | 1,014,536 | +0.9% | 0.00% | -66.7% |
| Q2 2016 | $7,311,000 | +52.0% | 1,005,689 | +7.9% | 0.01% | +50.0% |
| Q1 2016 | $4,811,000 | -36.1% | 932,411 | +3.9% | 0.01% | -40.0% |
| Q4 2015 | $7,533,000 | +19.2% | 897,843 | +0.5% | 0.01% | +11.1% |
| Q3 2015 | $6,318,000 | -37.5% | 893,686 | -1.6% | 0.01% | -30.8% |
| Q2 2015 | $10,113,000 | +86.0% | 907,846 | +38.1% | 0.01% | +85.7% |
| Q1 2015 | $5,437,000 | +41.6% | 657,438 | +1.5% | 0.01% | +40.0% |
| Q4 2014 | $3,841,000 | +41.5% | 647,726 | -0.5% | 0.01% | +25.0% |
| Q3 2014 | $2,714,000 | +2.8% | 650,872 | +13.9% | 0.00% | 0.0% |
| Q2 2014 | $2,639,000 | +12.9% | 571,211 | +10.7% | 0.00% | +33.3% |
| Q1 2014 | $2,337,000 | -10.4% | 515,902 | +1.3% | 0.00% | -25.0% |
| Q4 2013 | $2,608,000 | +117.0% | 509,291 | +33.4% | 0.00% | +100.0% |
| Q3 2013 | $1,202,000 | +65.6% | 381,737 | +7.8% | 0.00% | +100.0% |
| Q2 2013 | $726,000 | – | 353,993 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |